DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Rilapladib is an investigational drug.
There have been 4 clinical trials for Rilapladib. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2011.
The most common disease conditions in clinical trials are Alzheimer Disease, Atherosclerosis, and [disabled in preview]. The leading clinical trial sponsors are GlaxoSmithKline and [disabled in preview].
Recent Clinical Trials for Rilapladib
|Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers||GlaxoSmithKline||Phase 1|
|A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) in Alzheimer's Disease||GlaxoSmithKline||Phase 2|
|An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks||GlaxoSmithKline||Phase 2|